Rushmore Investment Advisors’s Biogen BIIB Stock Holding History

Rushmore Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$1.71M	Buy	+7,958	New	+$1.7M	0.35%	90

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Rushmore Investment Advisors's BIIB Position: Q2 2013 in Review

Rushmore Investment Advisors opened a new position in Biogen (BIIB) in Q2 2013: 7,958 shares worth $1.71M. The stake represents 0.35% of the portfolio and ranks #90 among its holdings.

646 funds tracked by Wall St. Rank hold BIIB as of Q2 2013.

Rushmore Investment Advisors held 7,958 shares of Biogen worth $1.71M as of Q2 2013.
Biogen was a new Rushmore Investment Advisors position in Q2 2013.
Biogen made up 0.35% of Rushmore Investment Advisors's portfolio in Q2 2013, its #90 holding.
646 funds tracked by Wall St. Rank held Biogen as of Q2 2013.

Based on Rushmore Investment Advisors's 13F filing for Q2 2013, filed 29 Aug 2013.